🔗 Share this article

While the United States continues making sweeping revisions to its vaccination schedules, an unexpected name appears unexpectedly: Høeg, a Danish American sports medicine doctor and epidemiologist who first made her name by questioning coronavirus vaccinations in the global health crisis and has zeroed in on potential deaths following Covid immunization in her brief tenure at the US Food and Drug Administration (FDA).

Proposed Changes to Childhood Immunization Schedule

Agency leaders planned to unveil sweeping revisions to the childhood vaccination calendar earlier this month, aligning the US with Denmark’s vaccine program, it is understood – a substantial departure that would put the US at odds with much of the international standard with insufficient data for public health gain. The announcement has been postponed until the new year.

Instead of the director of the vaccine center, Høeg is scheduled to present at the gathering. She was just designated interim head of the FDA’s CDER, the fifth individual to lead the center this year.

Consolidating Power at the FDA

Høeg's temporary position may indicate a closer partnership between the drug and vaccine centers as Høeg and Dr. Prasad consolidate power at the agency – and it signals a increased emphasis upon rolling back long-standing vaccines at the FDA.

Høeg has frequently advocated for halting some childhood immunization guidelines in the US so as to align more similar to Denmark, a society with nationalized medicine and a number of inhabitants about the population of Wisconsin’s.

To date statements, she has kept her attention on vaccines – usually the domain of Prasad, director of the FDA’s vaccine center – as opposed to medication approval.

Questions Over Expertise

The appointee has no apparent track record in pharmaceutical research, approval processes or leadership, which has been typical for former leaders of the Center for Biologics Evaluation and Research. She has been employed at the FDA as a senior adviser to the FDA chief and the vaccine center since earlier this year.

“She appears not to have the necessary background” for leading the drug-regulation department, remarked a neurologist and psychiatrist. “She has not conducted a clinical trial. She lacks experience in managing a sizeable institution. She is not an expert in pharmaceutical oversight.”

Past heads of CBER would “grasp laws and regulations and the science of pharmaceutical innovation”, noted a former acting FDA commissioner. “Frankly, she has not acquired the sort of resume that previous people who led the center have had.”

CDER has an vast range of responsibilities at the agency, the former commissioner stated.

“Everybody just focuses on the innovative therapies, but the generic program approves thousands of off-brand pharmaceuticals. There is also a biosimilars division, over-the-counter program and other areas, and all of those must be looked after,” she explained. “The area you neglect, that is precisely what that I always told people is going to come back to haunt you.”

Additionally, a significant leadership element to the role, which oversees in excess of 5,000 personnel. “It’s a massive management job, if you perform it correctly,” she said.

Agency Reaction and Controversial Policies

When asked about inquiries about Dr. Høeg's credentials and whether this assignment represents greater collaboration among agency officials on immunizations, a press secretary responded that the “inquiries stem from flawed presumptions”.

“This background aligns with the responsibilities of her role,” the official explained, pointing to the months Dr. Høeg spent counseling the agency head on “medication safety and regulatory science, including computational safety modeling and immunization monitoring”.

As acting director, Høeg assumes responsibility for the agency head's controversial priority voucher program, a disputed one-day medication authorization process that allegedly worried her preceding directors. “By what process are these therapies being picked for this voucher program? Who takes the choices?” Dr. Howard said. “There is a lot of secrecy occurring at the regulatory body right now.”

Overall, he stated, “the FDA looks to be trending towards more relaxed regulations of all drugs, aside from shots.”

Documented Track Record on Vaccines

Regarding immunizations, Høeg has a clearer, if concerning, track record, Howard have noted. She released a analysis using unconfirmed volunteer-provided data to determine the rate of myocarditis after COVID-19 immunization. She advised the Florida chief medical officer Dr. Joseph Ladapo, who reportedly have modified findings to imply Covid vaccinations are more dangerous than they are.

Among her “wish list” for the incoming government featured changing guidelines for novel immunizations and ending “non-essential” vaccines, she said following the vote on a online show. At the agency, Høeg has reportedly proposed barring young men from getting COVID-19 vaccinations.

“She is an thorough ideologue who begins with her conclusions and works backwards to fit the science in a very disingenuous, untruthful way,” Howard stated.

Taking Control and a “Revenge Tour”

Dr. Høeg aligned with fellow skeptics, {like|